BMO Capital Markets initiated coverage on Novartis AG with a new price target

2/23/24 7:12:32 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

BMO Capital Markets initiated coverage of Novartis AG with a rating of Market Perform and set a new price target of $114.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$NVS

Date	Price Target	Rating	Analyst
2/13/2025		Buy → Neutral	UBS
2/12/2025		Underweight	Morgan Stanley
2/4/2025		Hold → Buy	Deutsche Bank
12/4/2024		Hold → Reduce	HSBC Securities
9/11/2024	$135.00 → $130.00	Buy → Neutral	BofA Securities
9/5/2024		Buy → Neutral	Goldman
9/3/2024		Buy → Hold	Jefferies
7/19/2024		Buy → Hold	Deutsche Bank